Coloplast A/S - Decisions at the Annual General Meeting 2025

Today, 4 December 2025, Coloplast A/S held its Annual General Meeting, at which the following resolutions were adopted:

• The annual report for the financial year 2024/25 was approved.
• Distribution of year-end dividend of DKK 18.00 per share of nominally DKK 1 was approved. In addition to the interim dividend of DKK 5.00 per share of nominally DKK 1 paid out in connection with Coloplast A/S’ half- year result, this brings the total dividend paid for the financial year 2024/25 to DKK 23.00 per share of nominally DKK 1.
• The remuneration report for the financial year 2024/25 was approved.
• The remuneration of the members of the Board of Directors for the financial year 2025/26 was approved.
• The remuneration policy was approved.
• Lars Rasmussen did not seek re-election to the Board of Directors. Jette Nygaard-Andersen, Niels Peter Louis-Hansen, Annette Brüls, Carsten Hellmann, and Marianne Wiinholt were re-elected to the Board of Directors. In addition, Niels B. Christiansen was elected as new member to the Board of Directors. 
• EY Godkendt Revisionspartnerselskab was re-elected as Coloplast A/S’ auditors. The election applies to statutory financial reporting as well as assurance engagements relating to sustainability reporting.
• Authorisation was granted to the chairman of the Annual General Meeting to make certain registrations with the Danish Business Authority and other authorities.

Immediately after the Annual General Meeting, the Board of Directors elected Jette Nygaard-Andersen as Chairman and Niels Peter Louis-Hansen as Deputy Chairman.

In addition to the members of the Board of Directors elected at the Annual General Meeting, the Board of Directors consists of three members elected by the employees: Thomas Barfod, Nikolaj Kyhe Gundersen and Roland Vendelbo Pedersen.

For further information, please contact

 

Investors and analysts

Anders Lonning-Skovgaard

Executive Vice President, CFO

Tel.

Kristine Husted Munk

Sr. Director, Investor Relations

Tel. /

Email: 

Simone Dyrby Helvind

Sr. Manager, Investor Relations

Tel. /

Email: 

Press and media

Peter Mønster

Head of Media Relations & Corporate Content

Tel.

Email: 

Address

Coloplast A/S

Holtedam 1

DK-3050 Humlebaek

Denmark

Company reg. (CVR) no. 69749917

Website

This announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail.

The Coloplast story begins back in 1954. Elise Sørensen is a nurse. Her sister Thora has just had an ostomy operation and is afraid to go out in public, fearing that her stoma might leak. Listening to her sister’s problems, Elise conceives the idea of the world’s first adhesive ostomy bag. Based on Elise’s idea, Aage Louis-Hansen, a civil engineer and plastics manufacturer, and his wife Johanne Louis Hansen, a trained nurse, created the ostomy bag. A bag that does not leak, giving Thora – and thousands of people like her – the chance to live the life they want. 

A simple solution that makes a difference.

Today, the Coloplast Group develops products and services that help millions of people live more independent lives through solutions tailored to their needs. Globally, our business areas include Ostomy Care, Continence Care, Voice & Respiratory Care, Wound & Tissue Repair, and Interventional Urology.

Attachment